Medicare Enrolled
Dr. Mark Rubin, M.D.
Hematology · Bonita Springs, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rubin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rubin? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rubin
Dr. Mark Rubin is a hematology in Bonita Springs, FL, with 20 years in practice. Based on federal Medicare data, Dr. Rubin performed 351,579 Medicare services across 6,549 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rubin received a total of $9,115 from 79 pharmaceutical and/or device companies across 263 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rubin is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 6% volume in FL$ $9,115 industry payments
Medicare Practice Summary
Medicare Utilization ↗351,579
Medicare services
Top 6% in FL for hematology
6,549
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~17,579 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 54,570 | $0 | $4 |
| Filgrastim injection (Zarxio) for white blood cells | 42,240 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 41,400 | $43 | $137 |
| Anti-nausea injection (aprepitant) | 25,740 | $1 | $5 |
| Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram | 25,740 | $0 | $2 |
| Oxaliplatin chemotherapy injection | 25,688 | $0 | $12 |
| Nivolumab injection (Opdivo) | 18,240 | $24 | $72 |
| Daratumumab injection (Darzalex) | 13,860 | $38 | $110 |
| Paclitaxel chemotherapy injection | 13,857 | $0 | $2 |
| Epoetin alfa injection (Procrit) for anemia | 12,170 | $6 | $23 |
| Azacitidine chemotherapy injection | 8,800 | $0 | $4 |
| Immune globulin infusion (Gammagard) | 7,822 | $36 | $108 |
| Iron sucrose injection (Venofer) | 6,600 | $0 | $5 |
| Dexamethasone injection (steroid) | 6,293 | $0 | $3 |
| Denosumab injection (Prolia/Xgeva) | 4,980 | $18 | $51 |
| Complete blood count (CBC) with differential | 4,090 | $8 | $29 |
| Blood draw (venipuncture) | 3,602 | $8 | $9 |
| Anti-nausea injection (Aloxi/palonosetron) | 3,571 | $1 | $28 |
| Injection, docetaxel, 1 mg | 2,722 | $1 | $7 |
| Anti-nausea injection (ondansetron/Zofran) | 2,510 | $0 | $9 |
| Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 2,480 | $22 | $185 |
| Injection, atropine sulfate, 0.01 mg | 2,440 | $0 | $1 |
| Injection, bortezomib, 0.1 mg | 2,310 | $5 | $113 |
| Injection, rituximab, 10 mg | 2,160 | $63 | $232 |
| Office visit, established patient (30-39 min) | 1,872 | $100 | $339 |
| Injection, leucovorin calcium, per 50 mg | 1,331 | $3 | $12 |
| Injection of additional new drug or substance into vein | 1,257 | $12 | $61 |
| Administration of chemotherapy into vein, 1 hour or less | 1,138 | $103 | $378 |
| Injection, fluorouracil, 500 mg | 1,092 | $2 | $7 |
| Drug injection, under skin or into muscle | 1,066 | $11 | $69 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 1,002 | $3 | $205 |
| Injection, fulvestrant, 25 mg | 960 | $9 | $132 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 743 | $23 | $84 |
| Office visit, established patient (20-29 min) | 742 | $67 | $239 |
| Infusion into a vein for hydration, each additional hour | 605 | $10 | $42 |
| Office visit, established patient, complex (40-54 min) | 434 | $142 | $474 |
| Administration of chemotherapy into vein, each additional hour | 426 | $23 | $79 |
| Infusion, normal saline solution , 1000 cc | 414 | $2 | $7 |
| Injection, diphenhydramine hcl, up to 50 mg | 402 | $1 | $3 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 376 | $49 | $189 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 373 | $1 | $6 |
| Injection, carboplatin, 50 mg | 367 | $2 | $41 |
| Infusion into a vein for hydration, 31-60 minutes | 305 | $26 | $156 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 289 | $18 | $59 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 263 | $16 | $56 |
| Administration of additional new drug or substance into vein, 1 hour or less | 261 | $51 | $178 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 233 | $134 | $562 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 178 | $57 | $206 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 172 | $26 | $89 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 166 | $132 | $637 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 158 | $1 | $7 |
| Injection, zoledronic acid, 1 mg | 157 | $7 | $69 |
| Injection, magnesium sulfate, per 500 mg | 144 | $1 | $2 |
| New patient office visit, complex (60-74 min) | 142 | $174 | $585 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 115 | $3 | $11 |
| Injection of drug or substance into vein | 106 | $29 | $156 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 94 | $16 | $56 |
| Administration of additional new drug or substance into vein using push technique | 73 | $45 | $170 |
| Automated urinalysis | 72 | $2 | $8 |
| Prothrombin time test (blood clotting) | 53 | $4 | $15 |
| Administration of chemotherapy into vein using push technique | 39 | $80 | $303 |
| Red blood count, automated test | 27 | $4 | $10 |
| Drawing of blood for a medical problem | 20 | $74 | $277 |
| Transitional care management services for problem of high complexity | 15 | $223 | $722 |
| Office visit, established patient (10-19 min) | 12 | $44 | $147 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
18.6% high complexity
78.0% medium
3.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,115
Total received (2018-2024)
Avg $1,302/year across 7 years
Top 45% in FL for hematology
79
Companies
263
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,310 (69.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,804 (30.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$783
2023$878
2022$2,398
2021$1,245
2020$2,096
2019$685
2018$1,030
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Aurobindo Pharma USA, Inc.
$1,664
AstraZeneca Pharmaceuticals LP
$1,303
Janssen Biotech, Inc.
$741
Incyte Corporation
$410
GENZYME CORPORATION
$347
Celgene Corporation
$303
TESARO, Inc.
$228
Merz North America, Inc.
$206
Daiichi Sankyo Inc.
$190
Sirtex Medical Inc
$168
Novartis Pharmaceuticals Corporation
$155
Merck Sharp & Dohme LLC
$154
Clovis Oncology, Inc.
$152
Genentech USA, Inc.
$152
Rigel Pharmaceuticals, Inc.
$149
Regeneron Healthcare Solutions, Inc.
$136
GlaxoSmithKline, LLC.
$119
NanoString Technologies, Inc.
$119
Astellas Pharma US Inc
$119
Puma Biotechnology, Inc.
$116
AbbVie, Inc.
$112
ABBVIE INC.
$105
Seagen Inc.
$104
Intuitive Surgical, Inc.
$96
ARRAY BIOPHARMA INC
$96
Myriad Genetic Laboratories, Inc.
$85
G1 Therapeutics, Inc.
$83
BeiGene USA, Inc.
$82
Amgen Inc.
$75
Karyopharm Therapeutics Inc.
$72
PFIZER INC.
$71
Alnylam Pharmaceuticals Inc.
$60
SpringWorks Therapeutics, Inc.
$56
TerSera Therapeutics LLC
$53
JAZZ PHARMACEUTICALS INC.
$51
MERZ NORTH AMERICA, INC.
$43
E.R. Squibb & Sons, L.L.C.
$42
Gilead Sciences, Inc.
$41
Takeda Pharmaceuticals U.S.A., Inc.
$39
Bayer HealthCare Pharmaceuticals Inc.
$39
Epizyme, Inc.,
$36
Kite Pharma, Inc.
$33
ADC Therapeutics America, Inc.
$33
Lilly USA, LLC
$32
Kyowa Kirin, Inc.
$32
Stemline Therapeutics Inc.
$31
Ipsen Biopharmaceuticals, Inc
$30
Foundation Medicine, Inc.
$29
EMD Serono, Inc.
$26
Pharmacyclics LLC, an AbbVie Company
$24
Veracyte, Inc.
$24
Mirati Therapeutics, Inc.
$23
Acrotech Biopharma Inc.
$23
Sun Pharmaceutical Industries Inc.
$21
EISAI INC.
$20
Merck Sharp & Dohme Corporation
$20
AMAG Pharmaceuticals, Inc.
$20
Secura Bio, Inc.
$20
SERVIER PHARMACEUTICALS LLC
$19
Eisai Inc.
$19
Array BioPharma Inc.
$18
Bayer Healthcare Pharmaceuticals Inc.
$17
Dendreon Pharmaceuticals LLC
$17
Helsinn Therapeutics (U.S.), Inc.
$16
Sysmex Inostics Inc
$16
Tempus AI, Inc
$15
GE HEALTHCARE
$15
Heron Therapeutics, Inc.
$15
PUMA BIOTECHNOLOGY, INC.
$15
Pharmacosmos Therapeutics Inc.
$14
Blueprint Medicines Corporation
$14
Myovant Sciences Inc.
$14
Octapharma USA, Inc.
$13
Acrotech Biopharma LLC
$13
Agios Pharmaceuticals, Inc.
$13
Pharmacyclics LLC, An AbbVie Company
$13
Jazz Pharmaceuticals Inc.
$11
SECURA BIO, INC.
$9
Emmaus Medical, Inc.
$5
Top 3 companies account for 40.7% of total payments
Associated products mentioned in payments ›
ADCETRIS · AKYNZEO · AYVAKIT · Aliqopa · BELEODAQ · BLENREP · BRAFTOVI · BRUKINSA · Bavencio · Beleodaq · Braftovi · BromSite (bromfenac ophthalmic solution) 0.075% · CALQUENCE · CERDELGA · CEREZYME · COPIKTRA · COSELA · Cinvanti · DARZALEX · DUPIXENT · Da Vinci Surgical System · ELAHERE · ENHERTU · ENJAYMO · Endari · Enhertu · FERAHEME · FOUNDATIONONE · Farydak · Folotyn · GAUCHER-DISEASE · GIVLAARI · IMBRUVICA · IMFINZI · INLYTA · INREBIC · JADENU · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LORBRENA · LYNPARZA · Lenvima · MONJUVI · NERLYNX · NINLARO · Nerlynx · Nplate · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · ONPATTRO · ONUREG · OPDIVO · ORGOVYX · Orserdu · PADCEV · PEMAZYRE · PLUVICTO · POTELIGEO · PRECISETUMOR · PROSIGNA ASSAY · PROVENGE · PYRUKYND · Padcev · Phesgo · Pomalyst · Quzyttir · REBLOZYL · RYBREVANT · RYDAPT · Rezlidhia · Rubraca · SARCLISA · SHINGRIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · Stivarga · TAGRISSO · TAZVERIK · TECVAYLI · TEPMETKO · TEVIMBRA · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Trodelvy · VENCLEXTA · VERZENIO · Venclexta · XOSPATA · XPOVIO · XTANDI · Xospata · Yescarta · ZEJULA · ZEPZELCA · Zoladex · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (69%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $3 per 100 Medicare services performed
Geographic Context
Hematologys within 10 mi
18
Per 100K population
2.3
County median income
$73,099
Nearest hospital
PHYSICIANS REGIONAL MEDICAL CENTER - PINE RIDGE
7.3 mi
7.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Rubin is a mixed practice specialist, with above-average Medicare volume (top 6% in FL), and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Rubin experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Rubin performed 54,570 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rubin receive payments from pharmaceutical companies?
Yes. Dr. Rubin received a total of $9,115 from 79 companies across 263 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rubin's costs compare to other hematologys in Bonita Springs?
Dr. Rubin's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rubin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologys in Bonita Springs
Browse hematologys in Bonita Springs ranked by procedure volume and transparency data.
Highest volume
Top Hematologys in FL
Hematologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologys in FL
Which FL hematologys receive the most from drug and device companies.
By company
Aurobindo Pharma USA, Inc. Payments to Doctors
See all physicians who received payments from Aurobindo Pharma USA, Inc..
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology